Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Myotonic Dystrophy Drug industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
F Hoffmann-La Roche Ltd
Isis Pharmaceuticals, Inc
BioMarin Pharmaceutical Inc
Valentia Biopharma SL
Genzyme Corporation
Marina Biotech, Inc
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
ISIS-DMPKRx
PRO-135
SRT-152
VAL-0411
Others
Application:
Hospital
Clinic
Home Use
Others
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Myotonic Dystrophy Drug Industry Overview
-
1.1.1 Myotonic Dystrophy Drug Market Scope and Market Segments
-
1.1.2 Myotonic Dystrophy Drug Industry Characteristics
-
1.1.3 Global and China Myotonic Dystrophy Drug Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Myotonic Dystrophy Drug Production Value and Growth Rate (2017-2028)
-
1.2 Global Myotonic Dystrophy Drug Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 ISIS-DMPKRx
-
1.2.2 PRO-135
-
1.2.3 SRT-152
-
1.2.4 VAL-0411
-
1.2.5 Others
-
1.3 Global Myotonic Dystrophy Drug Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Hospital
-
1.3.2 Clinic
-
1.3.3 Home Use
-
1.3.4 Others
-
1.4 Market Analysis by Region
-
1.4.1 North America Myotonic Dystrophy Drug Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Myotonic Dystrophy Drug Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Myotonic Dystrophy Drug Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Myotonic Dystrophy Drug Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Myotonic Dystrophy Drug Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Myotonic Dystrophy Drug Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Myotonic Dystrophy Drug Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Myotonic Dystrophy Drug Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Myotonic Dystrophy Drug Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Myotonic Dystrophy Drug Industry Porter's Five Forces Model Analysis
-
2.2.3 Myotonic Dystrophy Drug Industry PEST Analysis
-
2.3 Myotonic Dystrophy Drug Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Myotonic Dystrophy Drug Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Myotonic Dystrophy Drug Industry
Chapter 3 Global and China Myotonic Dystrophy Drug Market, by Manufacturer
-
3.1 Global and China Myotonic Dystrophy Drug Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Myotonic Dystrophy Drug Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Myotonic Dystrophy Drug Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Myotonic Dystrophy Drug Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Myotonic Dystrophy Drug Market Top 3 Players
Chapter 4 Global and China Myotonic Dystrophy Drug Market, by Type (2017-2028)
-
4.1 Myotonic Dystrophy Drug Market Trend, by Type
-
4.2 Global Myotonic Dystrophy Drug Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Myotonic Dystrophy Drug Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Myotonic Dystrophy Drug Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Myotonic Dystrophy Drug Price Trend, by Type (2017-2028)
-
4.3 China Myotonic Dystrophy Drug Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Myotonic Dystrophy Drug Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Myotonic Dystrophy Drug Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Myotonic Dystrophy Drug Price Trend, by Type (2017-2028)
Chapter 5 Global and China Myotonic Dystrophy Drug Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Myotonic Dystrophy Drug Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Myotonic Dystrophy Drug Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Myotonic Dystrophy Drug Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Myotonic Dystrophy Drug Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Myotonic Dystrophy Drug Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Myotonic Dystrophy Drug Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Myotonic Dystrophy Drug Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Myotonic Dystrophy Drug Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Myotonic Dystrophy Drug Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Myotonic Dystrophy Drug Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Myotonic Dystrophy Drug Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Myotonic Dystrophy Drug Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Myotonic Dystrophy Drug Market Analysis
-
7.1 North America Myotonic Dystrophy Drug Market, by Type
-
7.2 North America Myotonic Dystrophy Drug Market, by Application
-
7.3 North America Myotonic Dystrophy Drug Market Analysis and Forecast, by Country
-
7.3.1 United States Myotonic Dystrophy Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Myotonic Dystrophy Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Myotonic Dystrophy Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Myotonic Dystrophy Drug Market Analysis
-
8.1 Europe Myotonic Dystrophy Drug Market, by Type
-
8.2 Europe Myotonic Dystrophy Drug Market, by Application
-
8.3 Europe Myotonic Dystrophy Drug Market Analysis and Forecast, by Country
-
8.3.1 Germany Myotonic Dystrophy Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Myotonic Dystrophy Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Myotonic Dystrophy Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Myotonic Dystrophy Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Myotonic Dystrophy Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Myotonic Dystrophy Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Myotonic Dystrophy Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Myotonic Dystrophy Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Myotonic Dystrophy Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Myotonic Dystrophy Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Myotonic Dystrophy Drug Market Analysis
-
9.1 APAC Myotonic Dystrophy Drug Market, by Type
-
9.2 APAC Myotonic Dystrophy Drug Market, by Application
-
9.3 APAC Myotonic Dystrophy Drug Market Analysis and Forecast, by Country
-
9.3.1 China Myotonic Dystrophy Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Myotonic Dystrophy Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Myotonic Dystrophy Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Myotonic Dystrophy Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Myotonic Dystrophy Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Myotonic Dystrophy Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Myotonic Dystrophy Drug Market Analysis
-
10.1 Latin America, Middle East and Africa Myotonic Dystrophy Drug Market, by Type
-
10.2 Latin America, Middle East and Africa Myotonic Dystrophy Drug Market, by Application
-
10.3 Latin America, Middle East and Africa Myotonic Dystrophy Drug Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Myotonic Dystrophy Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Myotonic Dystrophy Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Myotonic Dystrophy Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Myotonic Dystrophy Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Myotonic Dystrophy Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Myotonic Dystrophy Drug Company Profiles
-
11.1 F Hoffmann-La Roche Ltd
-
11.1.1 F Hoffmann-La Roche Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 F Hoffmann-La Roche Ltd Myotonic Dystrophy Drug Product Profiles, Application and Specification
-
11.1.3 F Hoffmann-La Roche Ltd Myotonic Dystrophy Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 Isis Pharmaceuticals, Inc
-
11.2.1 Isis Pharmaceuticals, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 Isis Pharmaceuticals, Inc Myotonic Dystrophy Drug Product Profiles, Application and Specification
-
11.2.3 Isis Pharmaceuticals, Inc Myotonic Dystrophy Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 BioMarin Pharmaceutical Inc
-
11.3.1 BioMarin Pharmaceutical Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 BioMarin Pharmaceutical Inc Myotonic Dystrophy Drug Product Profiles, Application and Specification
-
11.3.3 BioMarin Pharmaceutical Inc Myotonic Dystrophy Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.4 Valentia Biopharma SL
-
11.4.1 Valentia Biopharma SL Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.4.2 Valentia Biopharma SL Myotonic Dystrophy Drug Product Profiles, Application and Specification
-
11.4.3 Valentia Biopharma SL Myotonic Dystrophy Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.5 Genzyme Corporation
-
11.5.1 Genzyme Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.5.2 Genzyme Corporation Myotonic Dystrophy Drug Product Profiles, Application and Specification
-
11.5.3 Genzyme Corporation Myotonic Dystrophy Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.6 Marina Biotech, Inc
-
11.6.1 Marina Biotech, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.6.2 Marina Biotech, Inc Myotonic Dystrophy Drug Product Profiles, Application and Specification
-
11.6.3 Marina Biotech, Inc Myotonic Dystrophy Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Myotonic Dystrophy Drug Industry Investment Prospect and Risk Assessment
-
12.1 Myotonic Dystrophy Drug Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Myotonic Dystrophy Drug Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Myotonic Dystrophy Drug Sales Volume and Growth Rate (2017-2028)
-
Figure China Myotonic Dystrophy Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Global Myotonic Dystrophy Drug Production Value and Growth Rate (2017-2028)
-
Figure China Myotonic Dystrophy Drug Production Value and Growth Rate (2017-2028)
-
Figure Global Myotonic Dystrophy Drug Market Size and Growth Rate of ISIS-DMPKRx (2017-2028)
-
Figure Global Myotonic Dystrophy Drug Market Size and Growth Rate of PRO-135 (2017-2028)
-
Figure Global Myotonic Dystrophy Drug Market Size and Growth Rate of SRT-152 (2017-2028)
-
Figure Global Myotonic Dystrophy Drug Market Size and Growth Rate of VAL-0411 (2017-2028)
-
Figure Global Myotonic Dystrophy Drug Market Size and Growth Rate of Others (2017-2028)
-
Figure Global Myotonic Dystrophy Drug Market Size and Growth Rate of Hospital (2017-2028)
-
Figure Global Myotonic Dystrophy Drug Market Size and Growth Rate of Clinic (2017-2028)
-
Figure Global Myotonic Dystrophy Drug Market Size and Growth Rate of Home Use (2017-2028)
-
Figure Global Myotonic Dystrophy Drug Market Size and Growth Rate of Others (2017-2028)
-
Figure North America Myotonic Dystrophy Drug Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Myotonic Dystrophy Drug Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Myotonic Dystrophy Drug Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Myotonic Dystrophy Drug Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Myotonic Dystrophy Drug Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Myotonic Dystrophy Drug Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Myotonic Dystrophy Drug Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Myotonic Dystrophy Drug Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Myotonic Dystrophy Drug Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Myotonic Dystrophy Drug Market Share, by Manufacturer in 2021
-
Figure Global and China Myotonic Dystrophy Drug Market Share, by Manufacturer in 2022
-
Table Global Myotonic Dystrophy Drug Sales Volume, by Type (2017-2028)
-
Table Global Myotonic Dystrophy Drug Sales Volume Share, by Type (2017-2028)
-
Figure Global Myotonic Dystrophy Drug Sales Volume Share, by Type (2017-2028)
-
Table Global Myotonic Dystrophy Drug Sales Value, by Type (2017-2028)
-
Table Global Myotonic Dystrophy Drug Sales Value Share, by Type (2017-2028)
-
Figure Global Myotonic Dystrophy Drug Price Trend, by Type (2017-2028)
-
Table China Myotonic Dystrophy Drug Sales Volume, by Type (2017-2028)
-
Table China Myotonic Dystrophy Drug Sales Volume Share, by Type (2017-2028)
-
Figure China Myotonic Dystrophy Drug Sales Volume Share, by Type (2017-2028)
-
Table China Myotonic Dystrophy Drug Sales Value, by Type (2017-2028)
-
Table China Myotonic Dystrophy Drug Sales Value Share, by Type (2017-2028)
-
Figure China Myotonic Dystrophy Drug Price Trend, by Type (2017-2028)
-
Table Global Myotonic Dystrophy Drug Sales Volume, by Application (2017-2028)
-
Table Global Myotonic Dystrophy Drug Sales Volume Share, by Application (2017-2028)
-
Figure Global Myotonic Dystrophy Drug Sales Volume Share, by Application (2017-2028)
-
Table Global Myotonic Dystrophy Drug Sales Value, by Application (2017-2028)
-
Table Global Myotonic Dystrophy Drug Sales Value Share, by Application (2017-2028)
-
Figure Global Myotonic Dystrophy Drug Sales Value Share, by Application (2017-2028)
-
Table China Myotonic Dystrophy Drug Sales Volume, by Application (2017-2028)
-
Table China Myotonic Dystrophy Drug Sales Volume Share, by Application (2017-2028)
-
Figure China Myotonic Dystrophy Drug Sales Volume Share, by Application (2017-2028)
-
Table China Myotonic Dystrophy Drug Sales Value, by Application (2017-2028)
-
Table China Myotonic Dystrophy Drug Sales Value Share, by Application (2017-2028)
-
Figure China Myotonic Dystrophy Drug Sales Value Share, by Application (2017-2028)
-
Figure China Myotonic Dystrophy Drug Production, Import, Consumption and Export (2017-2022)
-
Figure North America Myotonic Dystrophy Drug Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Myotonic Dystrophy Drug Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Myotonic Dystrophy Drug Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Myotonic Dystrophy Drug Production, Import, Consumption and Export (2017-2022)
-
Table North America Myotonic Dystrophy Drug Sales Volume, by Type (2017-2028)
-
Table North America Myotonic Dystrophy Drug Sales Volume Share, by Type (2017-2028)
-
Figure North America Myotonic Dystrophy Drug Sales Volume Share, by Type (2017-2028)
-
Table North America Myotonic Dystrophy Drug Sales Volume, by Application (2017-2028)
-
Table North America Myotonic Dystrophy Drug Sales Volume Share, by Application (2017-2028)
-
Figure North America Myotonic Dystrophy Drug Sales Volume Share, by Application (2017-2028)
-
Figure United States Myotonic Dystrophy Drug Sales Volume and Growth Rate (2017-2028)
-
Figure United States Myotonic Dystrophy Drug Sales Value and Growth Rate (2017-2028)
-
Figure Canada Myotonic Dystrophy Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Myotonic Dystrophy Drug Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Myotonic Dystrophy Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Myotonic Dystrophy Drug Sales Value and Growth Rate (2017-2028)
-
Table Europe Myotonic Dystrophy Drug Sales Volume, by Type (2017-2028)
-
Table Europe Myotonic Dystrophy Drug Sales Volume Share, by Type (2017-2028)
-
Figure Europe Myotonic Dystrophy Drug Sales Volume Share, by Type (2017-2028)
-
Table Europe Myotonic Dystrophy Drug Sales Volume, by Application (2017-2028)
-
Table Europe Myotonic Dystrophy Drug Sales Volume Share, by Application (2017-2028)
-
Figure Europe Myotonic Dystrophy Drug Sales Volume Share, by Application (2017-2028)
-
Figure Germany Myotonic Dystrophy Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Myotonic Dystrophy Drug Sales Value and Growth Rate (2017-2028)
-
Figure UK Myotonic Dystrophy Drug Sales Volume and Growth Rate (2017-2028)
-
Figure UK Myotonic Dystrophy Drug Sales Value and Growth Rate (2017-2028)
-
Figure France Myotonic Dystrophy Drug Sales Volume and Growth Rate (2017-2028)
-
Figure France Myotonic Dystrophy Drug Sales Value and Growth Rate (2017-2028)
-
Figure Italy Myotonic Dystrophy Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Myotonic Dystrophy Drug Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Myotonic Dystrophy Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Myotonic Dystrophy Drug Sales Value and Growth Rate (2017-2028)
-
Figure Spain Myotonic Dystrophy Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Myotonic Dystrophy Drug Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Myotonic Dystrophy Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Myotonic Dystrophy Drug Sales Value and Growth Rate (2017-2028)
-
Figure Poland Myotonic Dystrophy Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Myotonic Dystrophy Drug Sales Value and Growth Rate (2017-2028)
-
Figure Russia Myotonic Dystrophy Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Myotonic Dystrophy Drug Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Myotonic Dystrophy Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Myotonic Dystrophy Drug Sales Value and Growth Rate (2017-2028)
-
Table APAC Myotonic Dystrophy Drug Sales Volume, by Type (2017-2028)
-
Table APAC Myotonic Dystrophy Drug Sales Volume Share, by Type (2017-2028)
-
Figure APAC Myotonic Dystrophy Drug Sales Volume Share, by Type (2017-2028)
-
Table APAC Myotonic Dystrophy Drug Sales Volume, by Application (2017-2028)
-
Table APAC Myotonic Dystrophy Drug Sales Volume Share, by Application (2017-2028)
-
Figure APAC Myotonic Dystrophy Drug Sales Volume Share, by Application (2017-2028)
-
Figure China Myotonic Dystrophy Drug Sales Volume and Growth Rate (2017-2028)
-
Figure China Myotonic Dystrophy Drug Sales Value and Growth Rate (2017-2028)
-
Figure Japan Myotonic Dystrophy Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Myotonic Dystrophy Drug Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Myotonic Dystrophy Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Myotonic Dystrophy Drug Sales Value and Growth Rate (2017-2028)
-
Figure India Myotonic Dystrophy Drug Sales Volume and Growth Rate (2017-2028)
-
Figure India Myotonic Dystrophy Drug Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Myotonic Dystrophy Drug Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Myotonic Dystrophy Drug Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Myotonic Dystrophy Drug Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Myotonic Dystrophy Drug Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Myotonic Dystrophy Drug Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Myotonic Dystrophy Drug Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Myotonic Dystrophy Drug Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Myotonic Dystrophy Drug Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Myotonic Dystrophy Drug Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Myotonic Dystrophy Drug Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Myotonic Dystrophy Drug Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Myotonic Dystrophy Drug Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Myotonic Dystrophy Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Myotonic Dystrophy Drug Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Myotonic Dystrophy Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Myotonic Dystrophy Drug Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Myotonic Dystrophy Drug Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Myotonic Dystrophy Drug Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Myotonic Dystrophy Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Myotonic Dystrophy Drug Sales Value and Growth Rate (2017-2028)
-
Table F Hoffmann-La Roche Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table F Hoffmann-La Roche Ltd Product Profiles, Application and Specification
-
Table F Hoffmann-La Roche Ltd Myotonic Dystrophy Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Isis Pharmaceuticals, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Isis Pharmaceuticals, Inc Product Profiles, Application and Specification
-
Table Isis Pharmaceuticals, Inc Myotonic Dystrophy Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table BioMarin Pharmaceutical Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table BioMarin Pharmaceutical Inc Product Profiles, Application and Specification
-
Table BioMarin Pharmaceutical Inc Myotonic Dystrophy Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Valentia Biopharma SL Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Valentia Biopharma SL Product Profiles, Application and Specification
-
Table Valentia Biopharma SL Myotonic Dystrophy Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Genzyme Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Genzyme Corporation Product Profiles, Application and Specification
-
Table Genzyme Corporation Myotonic Dystrophy Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Marina Biotech, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Marina Biotech, Inc Product Profiles, Application and Specification
-
Table Marina Biotech, Inc Myotonic Dystrophy Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
